/
HMGN
$0.00+$0.00 (+766.67%)prev close
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.00 – $0.13
2% from low
Exchange
OTC Link
CS
Borrow rate
0.25%
Easy to borrow
Price (6 mo)
Loading chart…
Change+$0.00
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $7.6M | $4.8M | $4.5M | $6.4M | $5.4M | $5.2M | $5.1M | $4.0M |
| Cost of revenue | $5.7M | $2.9M | $2.6M | $3.6M | $3.3M | $2.9M | $3.2M | $2.4M |
| Gross profit | $1.9M | $1.9M | $1.9M | $2.8M | $2.1M | $2.4M | $2.0M | $1.6M |
| Gross margin | 25.2% | 39.9% | 41.9% | 43.5% | 38.2% | 45.1% | 38.1% | 39.9% |
| R&D | $281.0K | $57.1K | $28.2K | $146.7K | $92.2K | $25.2K | $5.0K | $44.6K |
| Operating income | −$875.1K | −$165.1K | −$158.8K | $118.0K | −$348.7K | $235.9K | −$472.7K | −$437.9K |
| EBITDA | −$359.3K | −$65.4K | −$57.1K | $225.6K | −$192.0K | $429.5K | −$284.0K | −$273.9K |
| Net income | −$1.3M | $312.9K | −$849.9K | $427.2K | −$808.1K | −$156.3K | −$880.5K | −$907.3K |
| Net margin | -17.6% | 6.6% | -18.9% | 6.7% | -14.9% | -3.0% | -17.1% | -22.4% |
| EPS (diluted) | -0.09 | 0.02 | -0.06 | 0.03 | -0.05 | -0.01 | -0.06 | -0.06 |
Annual figures · source: Financial Modeling Prep
Peer comparison
HEMAGEN DIAGNOSTICS INC
HEMAGEN DIAGNOSTICS INC
Held by traders on TradeandTell
No one on the platform currently holds HMGN.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in HMGN as of their last filing.
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded HMGN yet.